How Spravato Helps with Depression

Get Started
how spravato helps with depression

If you’ve tried two or more antidepressants of adequate dose and duration without finding meaningful relief, you’re not alone—and you haven’t failed.

More importantly, you do not have to feel like you have to give up to Major Depressive Disorder.

Treatment-resistant depression (TRD) affects many individuals, but a breakthrough FDA-approved nasal spray treatment called Spravato (Esketamine) offers new hope through an entirely different approach to healing.

Key Takeaways

  • Spravato targets glutamate instead of serotonin: Unlike conventional antidepressants, Spravato blocks NMDA receptors in the brain’s glutamate system, creating rapid chemistry changes for treatment-resistant depression.
  • Faster relief than traditional medications: Many patients see improvements within days or weeks versus the months required for conventional antidepressants, with some noticing changes within 24 hours.
  • FDA-approved specifically for treatment-resistant depression: The only approved esketamine treatment for patients who haven’t responded to at least two previous antidepressant trials of adequate dose and duration.
  • Requires supervised clinical administration: Administered as nasal spray under medical supervision in clinical settings, with 2-hour sessions and transportation needed since driving isn’t recommended afterward.

How Spravato Helps with Depression

Spravato is an Esketamine nasal spray, administred by specialized medical professionals. Unlike Ketamine IV infusions (which are used for chronic pain conditions), Esketamine has been studied in clinical trials and has undergone rigorous testing, so it is FDA-approved depression treatment.

A Different Mechanism

While traditional antidepressants work on serotonin or norepinephrine pathways, Spravato takes a revolutionary approach by targeting your brain’s glutamate system.

If your previous treatments haven’t been effective and your depression symptoms have persisted, it is likely you are treatment-resistant. However, Spravato works through a different mechanism. Spravato’s unique approach to the glutamate system means you now have access to a transformative therapy that may finally provide the relief you’ve been seeking.

This breakthrough treatment blocks NMDA receptors, creating rapid changes in brain chemistry that can help alleviate depressive symptoms and restore hope when other medications haven’t worked. The science behind this different choice represents decades of research into new pathways for Major Depressive Disorder relief.

It is worth mentioning that the Ketamine dose for depression may vary depending on your symptoms and how your body is responding to the treatment. Your healthcare provider will work with you to assess adequate dosage for maximum impact, so you can start reaping the benefits of this treatment as soon as possible (and as sustainably as possible).

Quicker Relief

Unlike traditional antidepressants that require weeks or months to take effect, many patients experience meaningful improvements with Spravato within days or weeks. This rapid relief can feel almost miraculous after the long journey of waiting for other treatments to work.

Clinical studies show that some individuals notice positive changes in mood and outlook as early as 24 hours after treatment. This quick response doesn’t just provide symptom relief—it restores hope and momentum in your healing journey, helping you feel like yourself again sooner.

Effective for Treatment-Resistant Depression

Unlike Ketamine infusion therapy, Spravato is specifically FDA-approved for individuals whose depression symptoms haven’t responded adequately to previous antidepressant trials (TRD or treatment-resistant depression).

This isn’t about being a difficult case, it’s about having access to the right treatment for your unique brain chemistry.

Can Be Combined with Oral Antidepressants

Spravato works alongside your current oral antidepressant, not as a replacement. This combination approach allows you to benefit from both the rapid-acting effects of this transformative therapy and the sustained support of your existing medication regimen.

You don’t have to start over or abandon treatments that may be providing some benefit. Instead, Spravato enhances your current approach, offering comprehensive support that addresses depression from multiple angles.

May Reduce Suicidal Thoughts

Spravato can provide a rapid reduction in suicidal ideation, offering crucial relief when you need it most. The quick onset of action makes this treatment particularly valuable during challenging periods when immediate support is essential.

For you and your loved ones, knowing that effective help is available provides both immediate relief and long-term peace of mind. The careful medical supervision that accompanies each treatment ensures you’re supported throughout your healing journey.

Convenient Administration

Spravato is administered in the presence of a healthcare professional, as a simple nasal spray in a serene, spa-like clinical environment designed specifically for your comfort and healing.

Treatment sessions occur twice weekly initially, then may reduce to weekly or every other week as you progress. Each visit includes approximately 2 hours of supportive care, including your treatment and a comfortable observation period.

The nasal spray format eliminates needles and complex procedures, while our calm, premium environment helps you feel relaxed and supported rather than anxious about medical settings.

How Spravato Works

Spravato contains Esketamine, a carefully formulated medication that rapidly crosses into your brain and creates positive changes in neural pathways associated with depression. Unlike other treatments you may have tried, it promotes the growth of new brain connections and supports your brain’s natural ability to heal and adapt.

This breakthrough treatment stimulates the release of proteins that help your neurons grow and form healthier patterns of communication, which helps with the relief of depressive symptoms. These changes in brain structure and function can lead to lasting improvements in how you feel and think about your life.

Want to know more about how Spravato makes you feel? We have guide for that, click the link and read our article on what most patients experience as a result of their treatment with Esketamine.

Administration by a Healthcare Professional

Every Spravato treatment takes place in our certified, spa-like clinical environment under the care of licensed professionals who specialize in this specific therapy. You’ll remain comfortable in our serene space for about 2 hours, allowing our team to monitor your well-being and ensure the best possible experience.

Our trained professionals handle all aspects of your care, from insurance coordination to treatment administration, removing the administrative burden from your shoulders so you can focus entirely on overcoming major depressive disorder symptoms and re-gaining a more posituve outlook on life.

!More info: If you want to know how long Ketamine nasal spray lasts, read our article about this to understand the length of the treatment, as well as how long the effects of Esketamine last in the body.

Clinical Studies and Spravato

Spravato’s FDA approval is grounded in rigorous clinical trials involving thousands of individuals with treatment-resistant depression. These studies consistently demonstrated significant improvements compared to placebo, providing the scientific foundation for this breakthrough treatment.

For example, the SUSTAIN-3 study is a large, open-label, long-term extension trial that evaluated the safety and effectiveness of intermittent esketamine nasal spray combined with an oral antidepressant in 1,148 adults with treatment-resistant depression (TRD) over a period of up to 4.5 years, totaling 2,769 patient-years of exposure.

The study demonstrated the clinical efficacy and safety of Spravato, with sustained improvements in depressive symptoms as measured by the MADRS scale, with nearly half of the participants achieving remission in the long term.

The safety profile remained consistent with prior shorter studies, with common adverse events such as dissociation, dizziness, nausea, headache, and transient blood pressure increases that resolved on the same day. No new safety concerns were identified, including no treatment-related interstitial or ulcerative cystitis. Cognitive function remained stable or improved slightly in adults under 65, and although reaction times slowed somewhat in older adults, overall cognition was maintained.

Serious adverse events were rare and infrequently attributed to esketamine, and discontinuation due to side effects was uncommon. While some participants experienced suicidal ideation and there was one unrelated suicide death, the overall tolerability was acceptable.

This clinical study also reported a 13.3% incidence of urinary tract infections, mostly among women, but these were not linked to the treatment. This interim analysis confirms esketamine nasal spray as a safe, effective long-term therapy for adults with TRD, supporting its use for sustained symptom relief with manageable and transient adverse effects during extended treatment periods.

It is worth noting that although there is some evidence Spravato can help with anxiety too, studies are still inconclusive. So while Spravato is 100% FDA-approved for treatment-resistant depression, treating other mental health conditions with the same medicine is still pending conclusive research.

Cons of Using Spravato for Depression

While Spravato can be a great option for patients suffering from Major Depressive Disorder, it is worth mentioning there are some disadvantages you need to consider.

Potential Side Effects

Like all effective treatments, Spravato can cause temporary adverse effects. The most common include brief feelings of disconnection, mild dizziness, nausea, or temporary changes in blood pressure. These effects typically occur during treatment and resolve within hours (as shown by the clinical study cited above).

Some patients experience dissociation—temporary feelings of detachment or altered perception. While these can feel unusual, our trained professionals are with you throughout each session to provide support and ensure your comfort and safety.

Accessibility

Spravato is available only through certified treatment centers like ours, which ensures the presence of healthcare providers and the highest standards of care.

Still, this may require travel depending on your location. The twice-weekly initial schedule requires planning, though we work with you to find convenient appointment times that fit your life.

It is worth mentioning that patient instructions include not driving for at least a couple of hours following the treatment, so it’s best if you arrange transportation if you have to travel to your clinical healthcare provider for the Spravato treatment.

The healthcare costs of the Spravato treatment may also be a concern for some of the patients. However, insurance coverage is often available, though prior authorization is required. Most of the major insurance providers cover Spravato, as it is an FDA-approved medical treatment.

Our team handles this entire insurance approval process for you. We will work with your insurance provider to secure coverage and remove financial barriers to your care.

The Need for Supervision

Each treatment requires medical supervision and a observation period, which means dedicating about 2 hours per session to your healing.

While this represents a time commitment, it also ensures your safety and provides professional support throughout your treatment journey.

You’ll need transportation arrangements since driving isn’t recommended for several hours after treatment. Many patients find this enforced rest period actually beneficial, providing dedicated time for self-care and reflection.

Abuse Risks

Esketamine is a controlled substance with potential for misuse, which is why it’s only available in certified clinical settings the supervision of a healthcare provider. Our protocols ensure safe administration while eliminating concerns and risks associated with home storage or self-administration.

The controlled clinical setting and careful patient screening minimize these risks while maximizing the therapeutic benefits of this breakthrough treatment.

Spravato vs Other Depression Treatments

Spravato and other treatments for Major Depressive Disorder do not have to be complete antagonists. Here’s how Esketamine compares with other depression treatments:

Traditional Antidepressants

Traditional antidepressants work through serotonin or norepinephrine systems and typically require 4-6 weeks to show full effects.

Spravato offers the advantage of rapid relief through the glutamate system, working alongside your current medications rather than replacing them. This combination approach provides both immediate support and sustained benefits.

Psychotherapy

Therapy remains an important part of comprehensive depression care, helping you develop coping strategies and process emotions. Spravato’s rapid mood improvements often make you more receptive to therapeutic work, creating a positive cycle of healing.

Many of our patients find that combining Spravato with ongoing therapy provides the most comprehensive support, addressing both the biological and emotional aspects of their depression. Of course, this should only be done with the indications of your mental healthcare professional.

Alternative Treatments

Other mental health treatment options for depression include ECT [Electroconvulsive Therapy], TMS [Transcranial Magnetic Stimulation], and VNS [Vagus Nerve Stimulation], each with distinct advantages and considerations.

Spravato offers rapid effectiveness without general anesthesia requirements, in a comfortable spa-like setting that feels more like self-care than medical treatment.

The choice depends on your individual needs, preferences, and treatment history. Our team helps you understand all options to make the best decision for your unique situation.

How Do You Know if Spravato Is Right for You?

You may be a good candidate for Spravato if you’ve tried at least two antidepressants of adequate dose and duration without sufficient relief, have health insurance that can cover this FDA-approved treatment, are looking for evidence-based care in a supportive environment, and can commit to regular treatment sessions.

Our clinical team conducts thorough evaluations to ensure Spravato is safe and appropriate for your specific health profile. We consider your medical history, current medications, and treatment goals to create a personalized care plan.

This breakthrough treatment works best for individuals who value scientific rigor, appreciate premium healthcare experiences, and are ready to try a different approach to healing. Our serene clinical environment and comprehensive care coordination remove barriers so you can focus on getting better.

If you’ve been searching for effective relief from treatment-resistant depression, Spravato represents genuine hope backed by FDA approval and clinical evidence. You deserve access to transformative therapy delivered with compassion and expertise in an environment designed for healing.

Remember, seeking this level of care isn’t a sign of failure—it’s a sign of strength and commitment to your well-being. We’re here to guide you through every step of this journey, handling the complexities of insurance and administration while providing the professional support you need to reclaim your life.

 

About Author

Amy Della Rocca

PMHNP – Clinical Director
Meet Amy Della Rocca, a Psychiatric Nurse Practitioner with experience in innovative mental health treatments. Amy’s credentials hail from Columbia University and her previous work experience is in Behavioral Health, Public health and Primary Care Medicine. Amy’s unwavering belief in the potential of ketamine treatment for mental well-being stems from hands-on experience with her patients. Witnessing its positive impact and lasting changes drove her to specialize in this unique field. What sets Amy apart is her holistic approach. She considers medical, emotional, and psychological aspects, earning respect for her practical solutions. Operating from Marpa, Amy evaluates patients for Spravato compatibility. She provides comprehensive on-site care during their Spravato treatment journey. Amy supports patients from evaluation to treatment completion and collaborates with their existing mental and physical health care team. Amy’s contribution goes beyond caregiving; she actively advances Ketamine Therapy. Her expertise and dedication have garnered trust among colleagues and patients alike.